Baxter’s Automated PD Systems

Compare the Amia System to our first automated PD System
HomeChoice Automated PD System

As the pioneer of home-based peritoneal dialysis (PD) therapy, Baxter has been providing PD patients with supplies to perform their treatments at home for more than 30 years. Baxter has leveraged its vast PD experience with the HomeChoice  System—first introduced to the market in 1994—to bring the innovative Amia Automated PD System with Sharesource Connectivity Platform to patients. Take a look at how the Amia System with Sharesource Platform compares to the HomeChoice/HomeChoice Pro Systems.

78.00

78% of Amia System patients consistently used voice guidance feature* 

In a simulated use study, participants rated the Amia System easier to use (including the step-by-step on-screen and voice guidance) than the HomeChoice System.1

82% of healthcare professionals would recommend the Amia System

In a simulated study** in which Healthcare Professionals reviewed current APD technology, 82% of HCPs agreed or strongly agreed that they would recommend the Amia System to some of their current APD patients over the HomeChoice System.1

82.00

Contact us block

For more information about the Amia System, connect with us
or talk to your healthcare provider.

Connect With Us

* Baxter Internal Data reported as of Jan 2017. Observational data only, not yet analyzed for statistical significance.
** Based on video demonstrations

1. Life Science Strategy Group. Peritoneal Dialysis Treatment Modality Assessment. Qualitative and Quantitative Research Report. December 2014. Baxter data on file. Available upon request.